Trial Profile
A Qualitative Prospective Study to Compare the Effectiveness of Neostigmine Versus Sugammadex in Length of PACU Stay in ASA II and III Patients Undergoing Sleeve Gastrectomy Bariatric Surgery
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2022
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 15 Jan 2019 Status changed from recruiting to discontinued.
- 12 Mar 2018 Status changed from not yet recruiting to recruiting.
- 19 Jan 2018 Planned End Date changed from 1 Aug 2018 to 1 Nov 2018.